Intology Founder at YC Paper Club: Drug Failures Stem From Picking Wrong Targets, Not Bad Molecules
yusufroohani · x · 2026-11-12
Yusuf Roohani of Intology, speaking at YC's Paper Club on AI for biology, argued that one of the biggest reasons drugs fail in the clinic is clinical efficacy — the field got very good at designing molecules and binding targets, but not at picking which targets to pursue in the first place, framing where AI can actually add value in drug discovery.
More from Companies & People
- Gary Marcus: WSJ reports Nvidia may fire Jensen Huang, warning the circular financing stack could collapse — Gary Marcus · 2026-11-12
- NYT reports Nvidia CEO Jensen Huang had affair with company executive, his second known one — burny_tech · 2026-11-12
- AI systems researcher moves lab to UT Austin in 2027 with multiple PhD openings — hongyangzh · 2026-11-12
- 'Like jumping on a mine labeled LANDMINE': AI circle reacts to Jensen Huang affair report — generativist · 2026-11-12
- Nvidia working with outside firm to find possible new CEO, weighs interim pick — zephyr_z9 · 2026-11-12
- Tim Cook floated as potential replacement for Nvidia CEO Jensen Huang — Polymarket · 2026-11-12